Table 3.
Clinical characteristics among oral hypoglycemic agent and injectable insulin users of diabetes study subjects
| Tested parameters | Diabetes treatment options
|
t-test | p-value | |
|---|---|---|---|---|
| Oral hypoglycemic agents (n=161) | Injectable insulin (n=53) | |||
| Age (years) | 42.57±13.4 | 44.11±9.9 | −0.894 | 0.373 |
| Fasting blood glucose (mg/dL) | 159.88±27.4 | 169.07±34.5 | −1.761 | 0.82 |
| Body mass index (kg/m2) | 26.3±4.86 | 25.65±3.35 | 1.084 | 0.281 |
| Waist and hip circumference (cm) | 1.5±0.59 | 1.22±0.43 | 3.778 | <0.0001* |
| Systolic blood pressure (mmHg) | 134.3±24.1 | 133.9±17.5 | 0.105 | 0.928 |
| Diastolic blood pressure (mmHg) | 87.2±13.2 | 91.8±12.8 | −2.255 | 0.025 |
Notes: Data were presented as mean (standard deviation).
*
p<0.05 indicates a significant difference. Independent t-test.